Literature DB >> 2858349

Avarol, a cytostatically active compound from the marine sponge Dysidea avara.

W E Müller, R K Zahn, M J Gasić, N Dogović, A Maidhof, C Becker, B Diehl-Seifert, E Eich.   

Abstract

A main metabolic product of the sponge Dysidea avara was isolated and purified and subsequently identified as avarol by applying a series of analytical techniques, e.g. [13C]NMR, [1H]NMR and i.r. spectroscopy. This sesquiterpenoid hydroquinone was found to possess strong cytostatic activity. Using the L5178y mouse lymphoma cell system in vitro (roller tube assays) avarol reduced cell growth to 50% at a concentration of 0.9 microM. Avarol treated cells did not show "unbalanced growth". Avarol interfered with mitotic processes, preventing telophase formation. Incorporation studies with precursors for DNA, RNA, protein and glycoprotein syntheses revealed increased incorporation rates in response to avarol treatment. From these results and further autoradiographical experiments it is suggested that inhibition of cell growth is due to changes of the intracellular pools and/or alterations of the permeability properties of the cell membrane for the precursors. Avarol diacetate caused the same cytostatic effect as avarol.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2858349     DOI: 10.1016/0742-8413(85)90130-6

Source DB:  PubMed          Journal:  Comp Biochem Physiol C        ISSN: 0742-8413


  10 in total

Review 1.  Sustainable production of bioactive compounds by sponges--cell culture and gene cluster approach: a review.

Authors:  Werner E G Müller; Vladislav A Grebenjuk; Gaël Le Pennec; Heinz- C Schröder; Franz Brümmer; Ute Hentschel; Isabel M Müller; Hans- J Breter
Journal:  Mar Biotechnol (NY)       Date:  2004-04-19       Impact factor: 3.619

2.  Evaluation of the activity of the sponge metabolites avarol and avarone and their synthetic derivatives against fouling micro- and macroorganisms.

Authors:  Maria Tsoukatou; Jean Philippe Maréchal; Claire Hellio; Irena Novaković; Srdan Tufegdzic; Dusan Sladić; Miroslav J Gasić; Anthony S Clare; Constantinos Vagias; Vassilios Roussis
Journal:  Molecules       Date:  2007-05-15       Impact factor: 4.411

Review 3.  Principles of biofouling protection in marine sponges: a model for the design of novel biomimetic and bio-inspired coatings in the marine environment?

Authors:  Werner E G Müller; Xiaohong Wang; Peter Proksch; Carole C Perry; Ronald Osinga; Johan Gardères; Heinz C Schröder
Journal:  Mar Biotechnol (NY)       Date:  2013-03-26       Impact factor: 3.619

4.  Primmorphs cryopreservation: a new method for long-time storage of sponge cells.

Authors:  Francesca Mussino; Marina Pozzolini; Laura Valisano; Carlo Cerrano; Umberto Benatti; Marco Giovine
Journal:  Mar Biotechnol (NY)       Date:  2012-11-15       Impact factor: 3.619

5.  Quantitative assessment of natural toxicity in sponges: toxicity bioassay versus compound quantification.

Authors:  Ruth Martí; Angelo Fontana; María-J Uriz; Guido Cimino
Journal:  J Chem Ecol       Date:  2003-06       Impact factor: 2.626

Review 6.  Reactivity and biological activity of the marine sesquiterpene hydroquinone avarol and related compounds from sponges of the order Dictyoceratida.

Authors:  Dusan Sladić; Miroslav J Gasić
Journal:  Molecules       Date:  2006-01-31       Impact factor: 4.411

7.  Investigating the Antiparasitic Potential of the Marine Sesquiterpene Avarone, Its Reduced form Avarol, and the Novel Semisynthetic Thiazinoquinone Analogue Thiazoavarone.

Authors:  Concetta Imperatore; Roberto Gimmelli; Marco Persico; Marcello Casertano; Alessandra Guidi; Fulvio Saccoccia; Giovina Ruberti; Paolo Luciano; Anna Aiello; Silvia Parapini; Sibel Avunduk; Nicoletta Basilico; Caterina Fattorusso; Marialuisa Menna
Journal:  Mar Drugs       Date:  2020-02-14       Impact factor: 5.118

Review 8.  Towards commercial production of sponge medicines.

Authors:  Marieke Koopmans; Dirk Martens; Rene H Wijffels
Journal:  Mar Drugs       Date:  2009-12-02       Impact factor: 5.118

Review 9.  Marine Invertebrate Metabolites with Anticancer Activities: Solutions to the "Supply Problem".

Authors:  Nelson G M Gomes; Ramesh Dasari; Sunena Chandra; Robert Kiss; Alexander Kornienko
Journal:  Mar Drugs       Date:  2016-05-21       Impact factor: 5.118

10.  Induction of gamma-interferon by avarol in human peripheral blood lymphocytes.

Authors:  R Voth; S Rossol; G Hess; H P Laubenstein; K H Meyer zum Büschenfelde; H C Schröder; M Bachmann; P Reuter; W E Müller
Journal:  Jpn J Cancer Res       Date:  1988-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.